Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Anticonvulsants and Caffeine

supplement:

Caffeine

Research Papers that Mention the Interaction

Caffeine reduces the efficacy of several anti-seizure medications , especially topiramate.
Current Neurology and Neuroscience Reports  •  2019  |  View Paper
Acute caffeine , in doses far below its convulsive potential (almost 10-20 fold lower than the ED50 of the … of 2.03 mmol/kg for the induction of seizures), produced a significant reduction in the anticonvulsant effects of carbamazepine, phenobarbital, phenytoin, and valproate … maximal electroshock-induced seizures in mice.
Przeglad lekarski  •  2007  |  View Paper
The overdose of caffeine produced a clinical picture that suggested neonatal seizures and prompted therapy with anticonvulsants.
American journal of diseases of children  •  1980  |  View Paper
Moreover, caffeine prevented from dantrolene anticonvulsant effects.
Acta medica Iranica  •  2016  |  View Paper
Pre-treatment (intraperirhinal cortex) of animals with the nonselective adenosine antagonist, caffeine (50 microM; 1 microl), blocked the anticonvulsant activity of 2-CLA.
Epilepsy Research  •  1999  |  View Paper
Intraperitoneal but not intrahippocampal pretreatment of animals with caffeine (50 mg/kg and 2 mM, respectively) blocked the anticonvulsant effects induced by intraperitoneal administration of 2-chloroadenosine.
Brain Research  •  1997  |  View Paper
Pretreatment with caffeine blocked the anticonvulsant effects of 2-CLA dose-dependently.
Brain Research  •  1997  |  View Paper
Caffeine in a single dose of 23.1 mg/kg reduced the anticonvulsant effect of PB.
Epilepsia  •  1996  |  View Paper
Caffeine sodium benzoate in doses of 0.0595‐0.476 mmol/ kg (11.55–92.4 mg/kg) distinctly reduced the anticonvulsant efficacy of PB, in the highest dose tested with an increase in ED50 value from 19.5 to 38 mg/kg.
Epilepsia  •  1990  |  View Paper
Further, when subconvulsant doses of caffeine and DMCM were combined, a synergistic action was observed.
Pharmacology Biochemistry and Behavior  •  1987  |  View Paper
Show More